The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

The Market Fieldbook

Company Observatory

JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

Overall research band Above average
Quality Mixed
Valuation Mixed
Balance sheet Above average
Market confirmation Strong

One-minute company read

What this report can tell you now

What the company does

Johnson & Johnson is a healthcare holding company that operates through two main segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on research, development, manufacture, and sale of products in areas such as immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment offers a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. Johnson & Johnson serves customers in the healthcare field by providing a range of medical and pharmaceutical products, generating revenue through the sale of these products.

The current research profile is Mixed Setup. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC21.7%Model input; read with the evidence status and period context.
Operating margin27.2%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years4.6%Model input; read with the evidence status and period context.
FCF margin20.9%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.